ProRS: A Protein Involved in Protein Synthesis and Degradation

Target Name: PARS2

NCBI ID: G25973

PARS2

ProRS: A Protein Involved in Protein Synthesis and Degradation

Pars2 (ProRS) is a protein that is expressed in the liver and is known for its role in the regulation of protein synthesis. ProRS has been shown to play a key role in the regulation of the translation of foreign proteins into the liver, and is often used as a drug target or biomarker for various diseases.

The protein encoded by the PRS2 gene is 19 kDa and has a calculated pI of 4.9. It is a single-pass transmembrane protein that is expressed in the liver and other organs. ProRS is a member of the TIR family, which includes proteins that are involved in the regulation of protein synthesis and translation.

One of the key functions of ProRS is its role in the regulation of protein synthesis. ProRS is known to interact with the translation machinery, which is responsible for translating the genetic information in DNA into proteins. ProRS is shown to play a key role in the regulation of the translation of foreign proteins into the liver, by interacting with the machinery to prevent the translation of foreign proteins that are not expressed in the liver.

In addition to its role in protein synthesis regulation, ProRS is also known to play a key role in the regulation of protein degradation. ProRS has been shown to interact with the protein degradation machinery, which is responsible for breaking down damaged or unnecessary proteins. ProRS is shown to play a key role in the regulation of protein degradation by interacting with the machinery to prevent the degradation of foreign proteins that are not expressed in the liver.

The role of ProRS in disease is an active area of research, and there are many potential drug targets and biomarkers that have been identified based on its unique functions. For example, ProRS has been shown to be involved in the regulation of alcohol consumption, and is thought to play a key role in the development of alcohol use disorder. In addition, ProRS has also been shown to be involved in the regulation of insulin sensitivity, and is thought to play a key role in the development of type 2 diabetes.

ProRS is also a potential biomarker for several diseases, including cancer. The regulation of protein synthesis and degradation by ProRS is known to be disrupted in many types of cancer, and it is thought that targeting ProRS may be an effective way to treat these diseases.

In conclusion, ProRS is a protein that is expressed in the liver and is known for its role in the regulation of protein synthesis and degradation. Its unique functions as a drug target or biomarker make it an attractive target for the development of new treatments for a variety of diseases. Further research is needed to fully understand the role of ProRS in disease and to develop effective treatments based on its unique functions.

Protein Name: Prolyl-tRNA Synthetase 2, Mitochondrial

The "PARS2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PARS2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets